CTNM
NASDAQ · Pharmaceuticals
Contineum Therapeutics Inc-A
$9.82
+0.26 (+2.72%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+295.3% upside
Low Target
$27.95
Average Target
$38.82
High Target
$46.43
Current Price
$9.82
Current
$9.82
$9.82
Target
$38.82
$38.82
$27.95
$38.82 avg
$46.43
Scenario Analysis
Bear Case
$27.95
184.6%
Low target
Base Case
$38.82
+295.3%
Avg target
Bull Case
$46.43
+372.8%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$17.79
-44.8% from high
52-Week Low
$6.73
+46.0% from low
Target vs 52W High
$38.82
+118.3% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $-0.46
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals